Compare Citius Pharmaceuticals Inc (CTXR) vs InMode Ltd (INMD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Citius Pharmaceuticals Inc vs InMode Ltd — how do they compare? Citius Pharmaceuticals Inc trades at $0.71 (market cap $20.01M), while InMode Ltd trades at $15.17 (market cap $872.08M). The key difference: InMode Ltd is far larger — about 43.6× Citius Pharmaceuticals Inc's market cap, and InMode Ltd is trading nearer its 52-week high, Citius Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| CTXR | INMD | |
|---|---|---|
Market Cap | $20.01M | $872.08M |
Sector | Health | Technology |
52-Week High | $1.82 | $16.62 |
52-Week Low | $0.48 | $12.76 |
Enterprise Value | $16.23M | $375.42M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Citius Pharmaceuticals Inc
Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.
Read more on CTXR →About InMode Ltd
InMode provides innovative medical technologies for minimally invasive surgical procedures. Its platforms use radiofrequency (RF) energy for aesthetic treatments like body contouring and skin tightening.
Read more on INMD →
